Concentrum Wealth Management

Position in ABBV — AbbVie Inc.

CIK 1765387 SAN JOSE, CA

Position in ABBV

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$609,472

+$120,990 QoQ

Shares Held

2,422

+7.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#2,992

of 4,152 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concentrum Wealth Management holds $3,763,659 across 6 Drug Manufacturers - General names. ABBV ranks #4 (16.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	3,991	$1,013,594
2	AMGN	Amgen Inc	1,954	$707,582
3	GILD	Gilead Sciences, Inc.	5,333	$673,771
4	ABBV	AbbVie Inc. This page	2,422	$609,472
5	MRK	Merck & Co., Inc.	3,939	$506,161
6	LLY	ELI LILLY & Co	211	$253,079

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$609,472	2,422	+7.8%	Shares	Sole	2026-08-06
2026-03-31	$488,482	2,246	—	Shares	Sole	2026-05-04
No filing history on record for this holder in this stock.